Samsung Biologics is accelerating its global expansion by establishing its first sales office in Europe, strengthening its ability to win contracts from leading pharmaceutical companies. The company is also expanding manufacturing capacity through its recent acquisition of a U.S. production facility and planned investments in new bio campuses in Songdo.
Samsung Biologics is accelerating its global expansion by establishing its first sales office in Europe, strengthening its ability to win contracts from leading pharmaceutical companies. The company is also expanding manufacturing capacity through its recent acquisition of a U.S. production facility and planned investments in new bio campuses in Songdo.
Share article
Related Content